Stereotaxis, Inc. (STXS)Healthcare | Medical Instruments & Supplies | Saint Louis, United States | NYSE American
1.60 USD
-0.04
(-2.439%) ⇩
(July 14, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 5:19 a.m. EDT
Stereotaxis presents a classic case of a 'strong buy' analyst recommendation colliding with a fundamentally broken business. While analysts see massive upside based on potential deal structures like the Robocath integration, the hard data tells a different story. The company is burning cash aggressively, with operating cash flow and free cash flow both deeply negative, and it is currently losing money on every dollar of revenue sold. The balance sheet is fragile, with debt significantly outweighing equity, and the return on equity is catastrophic. The price action confirms this distress; despite a recent recovery in the trailing twelve-month view, the stock is still trading well below its two-year average, reflecting the market's skepticism about the company's ability to sustain operations without further dilution or capital infusion. With no dividend to provide income and a statistical forecast model showing low confidence in any short-term directional move, there is no immediate catalyst to justify a bullish entry. The gap between the optimistic analyst targets and the reality of negative earnings and cash burn creates a high-risk environment where the thesis relies entirely on future execution rather than current financial health. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.039918 |
| AutoETS | 0.039919 |
| MSTL | 0.040071 |
| AutoTheta | 0.041801 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 5.20 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.409 |
| Excess Kurtosis | 0.37 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 26.942 |
| Revenue per Share | 0.333 |
| Market Cap | 159,089,904 |
| Forward P/E | -12.63 |
| Beta | 1.34 |
| Profit Margins | -69.50% |
| Website | https://www.stereotaxis.com |
As of July 11, 2026, 5:19 a.m. EDT: Options activity is extremely thin with negligible open interest across all expirations. There is virtually no speculative positioning in either calls or puts, indicating a lack of active trader conviction or significant capital flow into this instrument. Implied volatility is low and inconsistent, suggesting the market is largely ignoring this name for directional bets.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.27111113 |
| Address1 | 710 North Tucker Boulevard |
| Address2 | Suite 110 |
| All Time High | 154.0146 |
| All Time Low | 0.47 |
| Ask | 0.0 |
| Ask Size | 2,000 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 631,200 |
| Average Daily Volume3 Month | 474,275 |
| Average Volume | 474,275 |
| Average Volume10Days | 631,200 |
| Beta | 1.34 |
| Bid | 0.64 |
| Bid Size | 19,500 |
| Board Risk | 7 |
| Book Value | 0.147 |
| City | Saint Louis |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.6 |
| Current Ratio | 1.561 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.6499 |
| Day Low | 1.59 |
| Debt To Equity | 26.942 |
| Display Name | Stereotaxis |
| Earnings Call Timestamp End | 1,778,617,800 |
| Earnings Call Timestamp Start | 1,778,617,800 |
| Earnings Timestamp | 1,778,616,000 |
| Earnings Timestamp End | 1,778,616,000 |
| Earnings Timestamp Start | 1,778,616,000 |
| Ebitda | -18,159,000 |
| Ebitda Margins | -0.58209 |
| Enterprise To Ebitda | -8.386 |
| Enterprise To Revenue | 4.881 |
| Enterprise Value | 152,282,720 |
| Eps Current Year | -0.19 |
| Eps Forward | -0.12667 |
| Eps Trailing Twelve Months | -0.24 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.8398 |
| Fifty Day Average Change | -0.23979998 |
| Fifty Day Average Change Percent | -0.13034025 |
| Fifty Two Week Change Percent | -27.111113 |
| Fifty Two Week High | 3.59 |
| Fifty Two Week High Change | -1.9899999 |
| Fifty Two Week High Change Percent | -0.55431753 |
| Fifty Two Week Low | 1.59 |
| Fifty Two Week Low Change | 0.00999999 |
| Fifty Two Week Low Change Percent | 0.006289302 |
| Fifty Two Week Range | 1.59 - 3.59 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,092,317,400,000 |
| Float Shares | 69,032,409 |
| Forward Eps | -0.12667 |
| Forward P E | -12.631247 |
| Free Cashflow | -8,817,875 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 131 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.53856 |
| Gross Profits | 16,801,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15323 |
| Held Percent Institutions | 0.43952 |
| Implied Shares Outstanding | 99,431,185 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,383,523,200 |
| Last Split Factor | 1,096:1000 |
| Long Business Summary | Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri. |
| Long Name | Stereotaxis, Inc. |
| Market | us_market |
| Market Cap | 159,089,904 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_34778 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -22,949,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 163,067,143 |
| Number Of Analyst Opinions | 4 |
| Open | 1.64 |
| Operating Cashflow | -15,348,000 |
| Operating Margins | -0.83055 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.31 |
| Phone | 314 678 6100 |
| Pre Market Change | 0.029999971 |
| Pre Market Change Percent | 1.8749982 |
| Pre Market Price | 1.63 |
| Pre Market Time | 1,784,102,971 |
| Previous Close | 1.64 |
| Price Eps Current Year | -8.421053 |
| Price Hint | 4 |
| Price To Book | 10.884354 |
| Price To Sales Trailing12 Months | 5.099689 |
| Profit Margins | -0.69499 |
| Quick Ratio | 1.05 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | -0.04 |
| Regular Market Change Percent | -2.43902 |
| Regular Market Day High | 1.6499 |
| Regular Market Day Low | 1.59 |
| Regular Market Day Range | 1.59 - 1.6499 |
| Regular Market Open | 1.64 |
| Regular Market Previous Close | 1.64 |
| Regular Market Price | 1.6 |
| Regular Market Time | 1,784,059,200 |
| Regular Market Volume | 672,219 |
| Return On Assets | -0.24739 |
| Return On Equity | -1.56124 |
| Revenue Growth | -0.158 |
| Revenue Per Share | 0.333 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 99,431,185 |
| Shares Percent Shares Out | 0.0436 |
| Shares Short | 4,263,016 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 3,880,419 |
| Short Name | Stereotaxis, Inc. |
| Short Percent Of Float | 0.051799998 |
| Short Ratio | 8.5 |
| Source Interval | 15 |
| State | MO |
| Symbol | STXS |
| Target High Price | 5.0 |
| Target Low Price | 3.5 |
| Target Mean Price | 4.125 |
| Target Median Price | 4.0 |
| Total Cash | 14,616,000 |
| Total Cash Per Share | 0.15 |
| Total Debt | 5,280,000 |
| Total Revenue | 31,196,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.24 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.24805 |
| Two Hundred Day Average Change | -0.64804995 |
| Two Hundred Day Average Change Percent | -0.28827205 |
| Type Disp | Equity |
| Volume | 672,219 |
| Website | https://www.stereotaxis.com |
| Zip | 63,101 |